This is an application for a K23 award for Carolyn Calfee, M.D., a senior postdoctoral fellow in pulmonary/critical care medicine at the University of California San Francisco. Dr. Calfee is beginning her career as a young investigator in pathogenesis-oriented clinical research in acute lung injury (ALI). This K23 award will allow Dr. Calfee to achieve several goals: (1) to develop expertise in the conduct of prospective clinical studies in ALI;(2) to obtain additional training in environmental medicine and genetic epidemiology;(3) to apply advanced biostatistical methodology to clinical and biological data in order to obtain insight into disease pathogenesis;and (4) to transition to independent investigator status. To achieve these goals, Dr. Calfee has assembled a mentoring team that includes her sponsor and primary mentor, Dr. Michael Matthay, an internationally recognized expert in translational research on ALI, and two key scientific advisors, Dr. Neal Benowitz, an expert in smoking-related biomarkers, and Dr. Mark Eisner, an expert in epidemiologic studies of both ALI and secondhand smoking. The contribution of cigarette smoke exposure (CSE) to ALI susceptibility has not been evaluated in prospective, rigorous clinical studies. Dr. Calfee's preliminary data indicate that CSE may be a major risk factor for developing ALI. Dr. Calfee will first test the hypothesis that active and passive CSE increase susceptibility to ALI in an ongoing cohort of 350 major trauma patients at high risk for ALI (Aim 1). She will then test this hypothesis in a broader group of patients by using the resources of ongoing cohort studies to perform a case-control study of patients with ALI and age-matched, critically ill controls (Aim 2). Novel biomarkers of CSE will be measured to compare short and long-term exposure in cases and controls, controlling for important confounders. Dr. Calfee will then investigate the mechanistic relationship between CSE and ALI by studying key biomarkers of endothelial injury, lung epithelial injury, and disordered coagulation in patients enrolled in the case-control study (Aim 3). These studies will provide Dr. Calfee with the data needed to prepare an R01 application focused on the relationship between CSE and ALI outcomes, including the role of gene-environment interactions. Public Health Relevance: ALI remains a common and frequently fatal cause of acute respiratory failure in critically ill patients, with no specific preventative strategies or therapies available. Therefore, studying the role of CSE in the development of ALI may help develop new therapies and will provide further rationale and support for measures to eliminate active and passive CSE.

Agency
National Institute of Health (NIH)
Institute
National Heart, Lung, and Blood Institute (NHLBI)
Type
Mentored Patient-Oriented Research Career Development Award (K23)
Project #
5K23HL090833-05
Application #
8306839
Study Section
Special Emphasis Panel (ZHL1-CSR-R (O1))
Program Officer
Colombini-Hatch, Sandra
Project Start
2008-08-01
Project End
2014-07-31
Budget Start
2012-08-01
Budget End
2013-07-31
Support Year
5
Fiscal Year
2012
Total Cost
$152,820
Indirect Cost
$11,320
Name
University of California San Francisco
Department
Internal Medicine/Medicine
Type
Schools of Medicine
DUNS #
094878337
City
San Francisco
State
CA
Country
United States
Zip Code
94143
Wang, Chen Yu; Calfee, Carolyn S; Paul, Devon W et al. (2014) One-year mortality and predictors of death among hospital survivors of acute respiratory distress syndrome. Intensive Care Med 40:388-96
Kornblith, Lucy Z; Kutcher, Matthew E; Redick, Brittney J et al. (2014) Fibrinogen and platelet contributions to clot formation: implications for trauma resuscitation and thromboprophylaxis. J Trauma Acute Care Surg 76:255-6; discussion 262-3
Calfee, Carolyn S; Delucchi, Kevin; Parsons, Polly E et al. (2014) Subphenotypes in acute respiratory distress syndrome: latent class analysis of data from two randomised controlled trials. Lancet Respir Med 2:611-20
Hsieh, S Jean; Zhuo, Hanjing; Benowitz, Neal L et al. (2014) Prevalence and impact of active and passive cigarette smoking in acute respiratory distress syndrome. Crit Care Med 42:2058-68
Cohen, Mitchell Jay; Call, Mariah; Nelson, Mary et al. (2012) Critical role of activated protein C in early coagulopathy and later organ failure, infection and death in trauma patients. Ann Surg 255:379-85
Kangelaris, Kirsten Neudoerffer; Sapru, Anil; Calfee, Carolyn S et al. (2012) The association between a Darc gene polymorphism and clinical outcomes in African American patients with acute lung injury. Chest 141:1160-9
Calfee, Carolyn S; Ware, Lorraine B; Glidden, David V et al. (2011) Use of risk reclassification with multiple biomarkers improves mortality prediction in acute lung injury. Crit Care Med 39:711-7
Meyer, Nuala J; Li, Mingyao; Feng, Rui et al. (2011) ANGPT2 genetic variant is associated with trauma-associated acute lung injury and altered plasma angiopoietin-2 isoform ratio. Am J Respir Crit Care Med 183:1344-53
Calfee, Carolyn S; Matthay, Michael A; Eisner, Mark D et al. (2011) Active and passive cigarette smoking and acute lung injury after severe blunt trauma. Am J Respir Crit Care Med 183:1660-5
Brown, Lisa M; Calfee, Carolyn S; Matthay, Michael A et al. (2011) A simple classification model for hospital mortality in patients with acute lung injury managed with lung protective ventilation. Crit Care Med 39:2645-51

Showing the most recent 10 out of 20 publications